Article info
Systematic review
Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis
- Correspondence to Dr Elizabeth Prsic, Yale School of Medicine, New Haven, CT 06510, USA; elizabeth.prsic{at}yale.edu
Citation
Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis
Publication history
- Received June 15, 2022
- Accepted August 17, 2022
- First published September 8, 2022.
Online issue publication
February 20, 2023
Article Versions
- Previous version (8 September 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.